BACKGROUND: Binge, as well as chronic, alcohol consumption affects global histone acetylation leading to changes in gene expression. It is becoming increasingly evident that these histone-associated epigenetic modifications play an important role in the development of alcohol-mediated hepatic injury. METHODS: C57BL/6 mice were gavaged 3 times (12-hour intervals) with ethanol (EtOH; 4.5 g/kg). Hepatic histone deacetylase (Hdac) mRNAs were assessed by qRT-PCR. Total HDAC activity was estimated by a colorimetric HDAC activity/inhibition assay. Histone acetylation levels were evaluated by Western blot. Liver steatosis and injury were evaluated by histopathology, plasma aminotransferase (ALT) activity, and liver triglyceride accumulation. Expression of fatty acid synthase (Fas) and carnitine palmitoyl transferase 1a (Cpt1a) was also examined. HDAC 9 association with Fas promoter was analyzed. RESULTS: Binge alcohol exposure resulted in alterations of hepatic Hdac mRNA levels. Down-regulation of HDAC Class I (Hdac 1), Class II (Hdac 7, 9, 10), and Class IV (Hdac 11) and up-regulation of HDAC Class I (Hdac 3) gene expression were observed. Correspondent to the decrease in HDAC activity, an increase in hepatic histone acetylation was observed. These molecular events were associated with microvesicular hepatic steatosis and injury characterized by increased hepatic triglycerides (48.02 ± 3.83 vs. 19.90 ± 3.48 mg/g liver, p < 0.05) and elevated plasma ALT activity (51.98 ± 6.91 vs. 20.8 ± 0.62 U/l, p < 0.05). Hepatic steatosis was associated with an increase in FAS and a decrease in CPT1a mRNA and protein expression. Fas promoter analysis revealed that binge EtOH treatment decreased HDAC 9 occupancy at the Fas promoter resulting in its transcriptional activation. CONCLUSIONS: Deregulation of hepatic Hdac expression likely plays a major role in the binge alcohol-induced hepatic steatosis and liver injury by affecting lipogenesis and fatty acid β-oxidation.
BACKGROUND: Binge, as well as chronic, alcohol consumption affects global histone acetylation leading to changes in gene expression. It is becoming increasingly evident that these histone-associated epigenetic modifications play an important role in the development of alcohol-mediated hepatic injury. METHODS: C57BL/6 mice were gavaged 3 times (12-hour intervals) with ethanol (EtOH; 4.5 g/kg). Hepatic histone deacetylase (Hdac) mRNAs were assessed by qRT-PCR. Total HDAC activity was estimated by a colorimetric HDAC activity/inhibition assay. Histone acetylation levels were evaluated by Western blot. Liver steatosis and injury were evaluated by histopathology, plasma aminotransferase (ALT) activity, and liver triglyceride accumulation. Expression of fatty acid synthase (Fas) and carnitine palmitoyl transferase 1a (Cpt1a) was also examined. HDAC 9 association with Fas promoter was analyzed. RESULTS: Binge alcohol exposure resulted in alterations of hepatic Hdac mRNA levels. Down-regulation of HDACClass I (Hdac 1), Class II (Hdac 7, 9, 10), and Class IV (Hdac 11) and up-regulation of HDACClass I (Hdac 3) gene expression were observed. Correspondent to the decrease in HDAC activity, an increase in hepatic histone acetylation was observed. These molecular events were associated with microvesicular hepatic steatosis and injury characterized by increased hepatic triglycerides (48.02 ± 3.83 vs. 19.90 ± 3.48 mg/g liver, p < 0.05) and elevated plasma ALT activity (51.98 ± 6.91 vs. 20.8 ± 0.62 U/l, p < 0.05). Hepatic steatosis was associated with an increase in FAS and a decrease in CPT1a mRNA and protein expression. Fas promoter analysis revealed that binge EtOH treatment decreased HDAC 9 occupancy at the Fas promoter resulting in its transcriptional activation. CONCLUSIONS: Deregulation of hepatic Hdac expression likely plays a major role in the binge alcohol-induced hepatic steatosis and liver injury by affecting lipogenesis and fatty acid β-oxidation.
Authors: Blythe D Shepard; Rohan A Joseph; George T Kannarkat; Tara M Rutledge; Dean J Tuma; Pamela L Tuma Journal: Hepatology Date: 2008-11 Impact factor: 17.425
Authors: Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg Journal: Biochem J Date: 2003-03-15 Impact factor: 3.857
Authors: Jun Li; Fawzia Bardag-Gorce; Joan Oliva; Jennifer Dedes; Barbara A French; Samuel W French Journal: Genes Nutr Date: 2009-12-04 Impact factor: 5.523
Authors: Roger H F Wong; Inhwan Chang; Carolyn S S Hudak; Suzanne Hyun; Hiu-Yee Kwan; Hei Sook Sul Journal: Cell Date: 2009-03-20 Impact factor: 41.582
Authors: Gail A Cresci; Bryan Glueck; Megan R McMullen; Wei Xin; Daniella Allende; Laura E Nagy Journal: J Gastroenterol Hepatol Date: 2017-09 Impact factor: 4.029
Authors: Shivendra D Shukla; Ricardo Restrepo; Annayya R Aroor; Xuanyou Liu; Robert W Lim; Jacob D Franke; David A Ford; Ronald J Korthuis Journal: J Pharmacol Exp Ther Date: 2019-07-01 Impact factor: 4.030
Authors: Krisstonia Spruiell; Afua A Gyamfi; Susan T Yeyeodu; Ricardo M Richardson; Frank J Gonzalez; Maxwell A Gyamfi Journal: J Pharmacol Exp Ther Date: 2015-07-09 Impact factor: 4.030
Authors: Javier Calleja-Conde; Victor Echeverry-Alzate; Elena Giné; Kora-Mareen Bühler; Roser Nadal; Rafael Maldonado; Fernando Rodríguez de Fonseca; Antoni Gual; Jose Antonio López-Moreno Journal: Br J Pharmacol Date: 2016-07-18 Impact factor: 8.739
Authors: Crystina L Kriss; Emily Gregory-Lott; Aaron J Storey; Alan J Tackett; Wayne P Wahls; Stanley M Stevens Journal: Alcohol Clin Exp Res Date: 2018-08-16 Impact factor: 3.455